Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Sabra Health Care REIT Q3 2026 Results: Net Income $28.6M, Up 26.9% YoY

Sabra Health Care REIT reported total revenues of $707.2 million for the nine months ended September 30, 2026, compared to $562.7 million in the prior year period. Net income attributable to Sabra decreased to $44.1 million from $128.4 million year-over-year, primarily driven by a $104.6 million provision for loan losses and other reserves.

Watch the Sabra Health Care REIT, Inc. earnings callFull call on the ALFA USA YouTube channel
Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue249.6190.0
Profit before tax26.421.7
Net income28.622.5
EPS (diluted, $ a share)$0.11$0.09

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+26.9%
Revenue, year on year+31.3%
Source

10-Q filed with the SEC, NASDAQ: SBRA. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Sabra Health Care REIT, Inc.: key numbers

Share price
$20.35Close, Nov 16
Market cap
$5.33B
Shares outstanding
261.96MLatest SEC cover page
Sector
Real Estate & Construction
Industry
Real Estate Investment TrustsSIC 6798

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Sabra Health Care REIT, Inc.

All →
11:37 AM ET Form 4
Insider Selling

Sabra Health Care REIT Insider Michael J. Foster Sells $210K of Stock

Michael J. Foster sold 10,000 shares of Sabra Health Care REIT, Inc. at $20.98 a share, worth $210K in total on Nov 11, 2026. Shares held after the trade: 72,834 (-12.1%).

Value
$210K
Shares
10,000
Price
$20.98
Holding change
-12.1%
Trade date
Nov 11, 2026
4:07 PM ET 8-K
Financial Results

Sabra Health Care REIT Financial Results

Sabra Health Care REIT reported Q3 2026 net income of $0.11 per diluted share and Normalized AFFO of $0.41 per share. The company updated its full-year 2026 guidance, raising its Normalized AFFO range to $1.600 - $1.610 per share, and highlighted $747.2 million in year-to-date investments with an 8.0% estimated yield.

Term
Q3 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.